Chandra Asri Pacific PT Tbk

Chandra Asri Pacific PT Tbk has a liquidity position that is below the industry median, with a current ratio of 4.21 and a debt-to-equity ratio of 0.69. The company's cash and equivalents amount to $497.2 million, but this is insufficient to cover its long-term debt of $1.88 billion, resulting in a negative net cash position. The company's free cash flow is negative at -$87.6 million, indicating a cash outflow from operations after capital expenditures. The company's profitability is weak, with a return on equity of -1.22% and a return on assets of -0.62%. These metrics are significantly below the industry median for commodity chemicals, which typically exhibit positive returns. The operating income is negative at -$29.3 million, and the net income is also negative at -$33.1 million, reflecting a challenging operating environment. Chandra Asri Pacific PT Tbk's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide detailed geographic revenue breakdowns, but its operations are primarily based in Indonesia. This concentration increases exposure to regional economic and regulatory risks. The company's growth trajectory is uncertain, with no analyst estimates indicating a strong buy or buy recommendation. The mean recommendation is 4.00, which is a sell rating, and one analyst has issued a sell recommendation. The company's revenue for the latest period is $471.9 million, but there is no clear indication of growth in the next fiscal year. The risk assessment for Chandra Asri Pacific PT Tbk indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, and the absence of a positive operating cash flow exacerbates this risk. The company has not issued any recent equity, and there is no indication of near-term dilution pressure. Recent events and filings do not provide significant insight into the company's strategic direction. The company's financial statements show a continued decline in profitability, and there are no recent transcripts or press releases indicating a turnaround strategy. The company's capital expenditures are negative, suggesting a reduction in investment in new projects.